参考文献/References:
［1］ 曹毛毛,陈万青.中国恶性肿瘤流行情况及防控现状［J］.中国肿瘤临床,2019,46(3):145-149.
［2］ WASTSON J D,CRICK F H.Molecular structure of nucleic acids:a structure for deoxyribose nucleic acid［J］.Nature,1953,171(4356):737-738.
［3］ SANGER F,NICKKEN S,COULSON A R.DNA sequencing with chain-terminating inhibitors［J］.Proc Natl Acad Sci U S A,1977,74(12):5463-5467.
［4］ MEYERSON M,GABRIEL S,GETZ G.Advances in understanding cancer genomes through second-generation sequencing［J］.Nat Rev Genet,2010,11(10):685-696.
［5］ MARGUKIES M,EGHOLM M,ALTMAN W E,et al.Genome sequencing in microfabricated high-density picolitre reactors［J］.Nature,2005,437(7057):376-380.
［6］ COLLINS F S,MORGAN M,PATRINOS A.The human genome project:lessons from large-scale biology［J］.Science,2003,300(5617):286-290.
［7］ VON BUBNOFF A.Next-generation sequencing:the race is on［J］.Cell,2008,132(5):721-723.
［8］ MARDIS E R.The impact of next-generation sequencing technology on genetics［J］.Trends Genet,2008,24(3):133-141.
［9］ NAKAGAWA H,WARDELL C P,FURUTA M,et al.Cancer whole-genome sequencing:present and future［J］.Oncogene,2015,34(49):5943-5950.
［10］ WITJIEWICZ A K,MCMILLAN E A,BALAJI U,et al.Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets［J］.Nat Commun,2015,6:6744.
［11］ KYROCHRISTOS I D,GLANTZOUNIS G K,ZIOGAS D E,et al.From clinical standards to translating next-generation sequencing research into patient care improvement for hepatobiliary and pancreatic cancers［J］.Int J Mol Sci,2017,18(1):180.
［12］ MARGULIES M,EGHOLM M,ALTMAN W E,et al.Genome sequencing in microfabricated high-density picolitre reactors［J］.Nature,2005,437(7057):376-380.
［13］ BENTLEY D R,BALASUBRAMANIAN S,SWERDLOW H P,et al.Accurate whole human genome sequencing using reversible terminator chemistry［J］.Nature,2008,456(7218):53-59.
［14］ ROTHBERG J M,HINZ W,REARICK T M,et al.An integrated semiconductor device enabling non-optical genome sequencing［J］.Nature,2011,475(7356):348-352.
［15］ MCCOMISH B J,HILLS S F,BIGGS P J,et al.Index-free de novo assembly and deconvolution of mixed mitochondrial genomes［J］.Genome Biol Evol,2010,2:410-424.
［16］ DARWANTO A,HEIN A M,STRAUSS S,et al.Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations,validated by the QIAGEN Therascreen PCR kit and alternative NGS platform［J］.BMC Cancer,2017,17(1):358.
［17］ EID J,FEHR A,GRAY J,et al.Real-time DNA sequencing from single polymerase molecules［J］.Science,2009,323(5910):133-138.
［18］ GRENINGER A L,NACCACHE S N,FEDERMAN S,et al.Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis［J］.Genome Med,2015,7:99.
［19］ PENDLETON M,SEBRA R,PANG A W,et al.Assembly and diploid architecture of an individual human genome via single-molecule technologies［J］.Nat Methods,2015,12(8):780-786.
［20］ ALEKSEYEV Y O,FAZELI R,YANG S,et al.A next-generation sequencing primer-how does it work and what can it do［J］.Acad Pathol,2018,5:2374289518766521.
［21］ KAN Z,ZHENG H,LIU X,et al.Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma［J］.Genome Res,2013,23(9):1422-33.
［22］ LU J,YIN J,DONG R,et al.Targeted sequencing of cancer-associated genes in hepatocellular carcinoma using next generation sequencing［J］.Mol Med Rep,2015,12(3):4678-4682.
［23］ OBA A,SHIMADA S,AKIYAMA Y,et al.ARID2 modulates DNA damage response in human hepatocellular carcinoma cells［J］.J Hepatol,2017,66(5):942-951.
［24］ YIN C,LI D Y,GUO X,et al.NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis［J］.Ann Oncol,2019,30(6):953-962.
［25］ ZUCMAN-ROSSI J,VILLANUEVA A,NAULT J C,et al.Genetic landscape and biomarkers of hepatocellular carcinoma［J］.Gastroenterology,2015，149(5):1226-1239.e4.
［26］ LAURENT-PUIG P,LEGOIX P,BLUTEAU O,et al.Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis［J］.Gastroenterology,2001,120(7):1763-1773.
［27］ JHUNJHUNWALA S,JIANG Z,STAWISKI E W,et al.Diverse modes of genomic alteration in hepatocellular carcinoma［J］.Genome Biol,2014,15(8):436.
［28］ HADJIHANNAS M V,BRCKNER M,JERCHOW B,et al.Aberrant wnt/beta-catenin signaling can induce chromosomal instability in colon cancer［J］.Proc Natl Acad Sci U S A,2006,103(28):10747-10752.
［29］ FANG J Z,LI C,LIU X Y,et al.Hepatocyte-specific arid1a deficiency initiates mouse steatohepatitis and hepatocellular carcinoma［J］.PLoS One,2015,10(11):e0143042.
［30］ ZHANG X F,CHAO J,PAN Q Z,et al.Overexpression of wwp1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma［J］.Oncotarget,2015,6(38):40920-40933.
［31］ ZHUANG R,ZHANG X,LU D,et al.lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-myb-regulated MEK/ERK signaling［J］.Mol Carcinog,2019,58(3):366-375.
［32］ ZHANG Z,LI X,SUN W,et al.Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis［J］.Cancer Lett,2017,397:33-42.
［33］ CHAVALIT T,NIMSAMER P,SIRIVASSANAMETHA K,et al.Hepatitis B virus-encoded microRNA (HBV-miR-3)regulates host gene PPM1A related to hepatocellular carcinoma［J］.Microrna,2020,9(3):232-239.
［34］ 徐红梅,周剑,倪兵.肝癌患者外周血单个核细胞circRNAs诊断价值分析［J］.免疫学杂志,2019,35(7):607-612.
［35］ CHEN P M,LI J R,LIU C C,et al.Metabolic pathways enhancement confers poor prognosis in p53 exon mutant hepatocellular carcinoma［J］.Cancer Inform,2020,19:1176935119899913.
［36］ 王惠国,蔡珂,韩鑫龙,等.青蒿素对肝癌细胞基因表达谱的影响［J］.安徽医科大学学报,2019,54(10):1540-1545.
相似文献/References:
[1]王克霞,张荣波,唐小龙,等.肝细胞性肝癌与乙型肝炎病毒感染相关性的研究[J].新乡医学院学报,1997,14(03):281.
[2]杨瑞民,张凯,李玉侠,等.巨块型肝癌肝动脉栓塞后无水酒精注射疗效观察[J].新乡医学院学报,1997,14(04):382.
[3]甄艳华,杨利霞.肝癌患者肝动脉血流动力学的彩色多普勒研究[J].新乡医学院学报,2008,25(01):062.
[4]沈洁,阮健,郑航,等.ZD6474对肝癌HepG2细胞的抑制作用[J].新乡医学院学报,2010,27(03):234.
[5]黄长山,余伟,王云检,等.外科Apgar评分在肝癌术后并发症预测中的应用 TitleFilter('chTitle');[J].新乡医学院学报,2010,27(04):365.
[6]孙春伟,吴广银.哺乳动物雷帕霉素靶蛋白对肝癌细胞系Hep3B中侧群细胞的影响[J].新乡医学院学报,2011,28(03):307.
[7]王 雷１,王煜霞２,薛会朝１. 肝癌患者肿瘤坏死因子α和白细胞介素８水平变化及其与临床病理特征的关系[J].新乡医学院学报,2015,32(08):735.
[8]罗羽田,李世朋,徐红伟,等.铁死亡在肝癌中的调控机制及作用研究进展[J].新乡医学院学报,2021,38(1):091.[doi:10.7683/xxyxyxb.2021.01.020]
[9]王政强,韩锋博.肝癌切除术联合肝动脉化疗栓塞术治疗中晚期肝癌疗效观察[J].新乡医学院学报,2021,38(10):957.[doi:10.7683/xxyxyxb.2021.10.012]
WANG Zhengqiang,HAN Fengbo.Effect of hepatectomy combined with transcatheter hepatic arterial chemoembolization in the treatment of middle-advanced liver cancer[J].Journal of Xinxiang Medical University,2021,38(2):957.[doi:10.7683/xxyxyxb.2021.10.012]
[10]李 妍,朱绍辉,张 彬.肝癌患者肝切除术后感染性并发症的相关危险因素分析[J].新乡医学院学报,2016,33(9):767.[doi:10.7683/xxyxyxb.2016.09.007]
LI Yan,ZHU Shao-hui,ZHANG Bin.Analysis of the risk factors for infectious complications in patients with hepatocellular carcinoma after hepatectomy[J].Journal of Xinxiang Medical University,2016,33(2):767.[doi:10.7683/xxyxyxb.2016.09.007]